2025-2029年全球血糖监测系统市场

全球血糖值监测系统市场预估在2024年至2029年间成长101.4亿美元，预测期内复合年增长率（CAGR）为10.0%。本报告对全球血糖值监测系统市场进行了全面分析，包括市场规模和预测、趋势、成长要素和挑战，以及对约25家公司的供应商分析。

该报告对当前市场状况、最新趋势和驱动因素以及整体市场环境进行了最新分析。市场成长的驱动因素包括血糖值监测设备报销政策的实施、糖尿病患者数量的成长以及新产品发布数量的增加。

本研究采用客观的方法，结合一手和二手资料，并参考了主要行业相关人员的意见。报告分析了主要企业，提供了全面的市场规模数据、区域细分市场分析以及供应商格局。报告同时提供了历史数据和预测数据。

研究指出，对持续血糖监测（CGM）设备日益增长的需求是未来几年推动全球血糖监测系统市场成长的主要因素之一。此外，捆绑式产品行销策略的日益普及和策略发展的不断推进预计也将显着提升市场需求。

目录

第一章执行摘要

第二章 Technavio 分析

• 价格、生命週期、顾客购买篮、采用率和购买标准分析
• 投入与差异化因素的重要性
• 混淆来源
• 驱动因素和挑战的影响

第三章 市场情势

• 市场生态系统
• 市场特征
• 价值链分析

第四章 市场规模

• 市场定义
• 市场区隔分析
• 2024年市场规模
• 2024-2029年市场展望

第五章 市场规模表现

• 2019-2023年全球血糖监测系统市场
• 2019-2023年产品细分市场分析
• 2019-2023年最终用户细分市场分析
• 适应症细分市场分析 2019-2023
• 2019-2023年区域细分市场分析
• 2019-2023年国家细分市场分析

第六章 定性分析

• 人工智慧对全球血糖监测系统市场的影响

第七章五力分析

• 五力分析概述
• 买方的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第八章 按产品进行市场细分

• 比较：按产品
• 自测血糖
• 连续血糖监测设备
• 按产品分類的市场机会

9. 按最终用户进行市场区隔

• 比较：按最终用户
• 医院
• 居家医疗
• 诊断中心
• 按最终用户分類的市场机会

第十章 依适应症进行市场细分

• 比较：依指示
• 2型糖尿病患者人数
• 1型糖尿病患者人数
• 按适应症分類的市场机会

第十一章 客户情况

第十二章 区域情势

• 区域细分
• 区域比较
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 荷兰
  • 西班牙
• 亚洲
  • 日本
  • 中国
  • 印度
  • 韩国
  • 印尼
• 世界其他地区
  • 澳洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非
  • 以色列
  • 土耳其
• 各区域的市场机会

第十三章：驱动因素、挑战与机会

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场机会

第十四章 竞争格局

• 概述
• 竞争格局
• 令人困惑的局面
• 产业风险

第十五章 竞争分析

• 公司简介
• 企业排名指数
• 公司市场定位
• Abbott Laboratories
• ARKRAY Inc.
• B.Braun SE
• Dexcom Inc.
• F. Hoffmann La Roche Ltd.
• i-SENS, Inc.
• Indigo Diabetes NV
• Intuity Medical Inc.
• Koninklijke Philips NV
• LifeScan IP Holdings LLC
• Medtronic Plc
• Nipro Corp.
• PHC Holdings Corp.
• Prodigy Diabetes Care LLC
• Ypsomed Holding AG

第十六章附录

The global blood glucose monitoring system market is forecasted to grow by USD 10140.0 mn during 2024-2029, accelerating at a CAGR of 10.0% during the forecast period. The report on the global blood glucose monitoring system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of reimbursement for bgm devices, growing prevalence of diabetes, increasing number of product launches.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global blood glucose monitoring system market is segmented as below:

By Product

• Self monitoring
• Continuous glucose monitoring devices

By End-User

• Hospitals
• Home care
• Diagnostic centers

By Indication

• Type-2 diabetes population
• Type-1 diabetes population

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rising demand for continuous blood glucose monitoring (cgm) devices as one of the prime reasons driving the global blood glucose monitoring system market growth during the next few years. Also, increased adoption of bundled product marketing strategy and growing number of strategic developments will lead to sizable demand in the market.

The report on the global blood glucose monitoring system market covers the following areas:

• Global blood glucose monitoring system market sizing
• Global blood glucose monitoring system market forecast
• Global blood glucose monitoring system market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global blood glucose monitoring system market vendors that include Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., B.Braun SE, Dexcom Inc., DiaMonTech AG, F. Hoffmann La Roche Ltd., GlySens Inc., i-SENS, Inc., Indigo Diabetes NV, Intuity Medical Inc., Koninklijke Philips NV, LifeScan IP Holdings LLC, Medtronic Plc, Nipro Corp., Ok Biotech Co Ltd., PHC Holdings Corp., Prodigy Diabetes Care LLC, WaveForm Technologies Inc., Ypsomed Holding AG. Also, the global blood glucose monitoring system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Indication
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

• 5.1 Global Blood Glucose Monitoring System Market 2019 - 2023
  • Historic Market Size - Data Table on Global Blood Glucose Monitoring System Market 2019 - 2023 ($ million)
• 5.2 Product segment analysis 2019 - 2023
  • Historic Market Size - Product Segment 2019 - 2023 ($ million)
• 5.3 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.4 Indication segment analysis 2019 - 2023
  • Historic Market Size - Indication Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on the global blood glucose monitoring system market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Self monitoring - Market size and forecast 2024-2029
• 8.4 Continuous glucose monitoring devices - Market size and forecast 2024-2029
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2024-2029
• 9.4 Home care - Market size and forecast 2024-2029
• 9.5 Diagnostic centers - Market size and forecast 2024-2029
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Indication

• 10.1 Market segments
• 10.2 Comparison by Indication
• 10.3 Type-2 diabetes population - Market size and forecast 2024-2029
• 10.4 Type-1 diabetes population - Market size and forecast 2024-2029
• 10.5 Market opportunity by Indication
  • Market opportunity by Indication ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • 12.3.1 US - Market size and forecast 2024-2029
  • 12.3.2 Canada - Market size and forecast 2024-2029
  • 12.3.3 Mexico - Market size and forecast 2024-2029
• 12.4 Europe - Market size and forecast 2024-2029
  • 12.4.1 Germany - Market size and forecast 2024-2029
  • 12.4.2 UK - Market size and forecast 2024-2029
  • 12.4.3 France - Market size and forecast 2024-2029
  • 12.4.4 Italy - Market size and forecast 2024-2029
  • 12.4.5 The Netherlands - Market size and forecast 2024-2029
  • 12.4.6 Spain - Market size and forecast 2024-2029
• 12.5 Asia - Market size and forecast 2024-2029
  • 12.5.1 Japan - Market size and forecast 2024-2029
  • 12.5.2 China - Market size and forecast 2024-2029
  • 12.5.3 India - Market size and forecast 2024-2029
  • 12.5.4 South Korea - Market size and forecast 2024-2029
  • 12.5.5 Indonesia - Market size and forecast 2024-2029
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • 12.6.1 Australia - Market size and forecast 2024-2029
  • 12.6.2 Brazil - Market size and forecast 2024-2029
  • 12.6.3 Argentina - Market size and forecast 2024-2029
  • 12.6.4 Colombia - Market size and forecast 2024-2029
  • 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
  • 12.6.6 UAE - Market size and forecast 2024-2029
  • 12.6.7 South Africa - Market size and forecast 2024-2029
  • 12.6.8 Israel - Market size and forecast 2024-2029
  • 12.6.9 Turkey - Market size and forecast 2024-2029
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Availability of reimbursement for BGM devices
  • Growing prevalence of diabetes
  • Increasing number of product launches
• 13.2 Market challenges
  • Lower diagnosis and treatment rate
  • High cost of blood glucose monitoring systems and supplies
  • Intense competition among companies
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities
  • Rising demand for continuous blood glucose monitoring (CGM) devices
  • Increased adoption of bundled product marketing strategy
  • Growing number of strategic developments

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 ARKRAY Inc.
  • ARKRAY Inc. - Overview
  • ARKRAY Inc. - Product / Service
  • ARKRAY Inc. - Key offerings
  • SWOT
• 15.6 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key news
  • B.Braun SE - Key offerings
  • SWOT
• 15.7 Dexcom Inc.
  • Dexcom Inc. - Overview
  • Dexcom Inc. - Product / Service
  • Dexcom Inc. - Key offerings
  • SWOT
• 15.8 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.9 i-SENS, Inc.
  • i-SENS, Inc. - Overview
  • i-SENS, Inc. - Product / Service
  • i-SENS, Inc. - Key offerings
  • SWOT
• 15.10 Indigo Diabetes NV
  • Indigo Diabetes NV - Overview
  • Indigo Diabetes NV - Product / Service
  • Indigo Diabetes NV - Key offerings
  • SWOT
• 15.11 Intuity Medical Inc.
  • Intuity Medical Inc. - Overview
  • Intuity Medical Inc. - Product / Service
  • Intuity Medical Inc. - Key offerings
  • SWOT
• 15.12 Koninklijke Philips NV
  • Koninklijke Philips NV - Overview
  • Koninklijke Philips NV - Business segments
  • Koninklijke Philips NV - Key news
  • Koninklijke Philips NV - Key offerings
  • Koninklijke Philips NV - Segment focus
  • SWOT
• 15.13 LifeScan IP Holdings LLC
  • LifeScan IP Holdings LLC - Overview
  • LifeScan IP Holdings LLC - Product / Service
  • LifeScan IP Holdings LLC - Key offerings
  • SWOT
• 15.14 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.15 Nipro Corp.
  • Nipro Corp. - Overview
  • Nipro Corp. - Business segments
  • Nipro Corp. - Key offerings
  • Nipro Corp. - Segment focus
  • SWOT
• 15.16 PHC Holdings Corp.
  • PHC Holdings Corp. - Overview
  • PHC Holdings Corp. - Business segments
  • PHC Holdings Corp. - Key offerings
  • PHC Holdings Corp. - Segment focus
  • SWOT
• 15.17 Prodigy Diabetes Care LLC
  • Prodigy Diabetes Care LLC - Overview
  • Prodigy Diabetes Care LLC - Product / Service
  • Prodigy Diabetes Care LLC - Key offerings
  • SWOT
• 15.18 Ypsomed Holding AG
  • Ypsomed Holding AG - Overview
  • Ypsomed Holding AG - Business segments
  • Ypsomed Holding AG - Key offerings
  • Ypsomed Holding AG - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations